These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1277222)

  • 1. Some studies on the distribution and effects of cyclophosphamide (NSC-26271) in normal and neoplastic tissue.
    Houghton PJ; Tew KD; Taylor DM
    Cancer Treat Rep; 1976 Apr; 60(4):459-64. PubMed ID: 1277222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential distribution of antitumor agents in primary and secondary tumors.
    Donelli MG; Colombo T; Broggini M; Garattini S
    Cancer Treat Rep; 1977 Oct; 61(7):1319-24. PubMed ID: 589598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies with cyclophosphamide labeled with phosphorus-32: nucleic acid alkylation and its effect on DNA synthesis in rat tumor and normal tissues.
    Tew KD; Taylor DM
    J Natl Cancer Inst; 1977 May; 58(5):1413-9. PubMed ID: 857031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the disposition of cyclophosphamide (NSC-26271) in tumor-bearing mice by means of gas chromatography-chemical ionization-mass fragmentography.
    Pantarotto C; Martini A; Belvedere G; Donelli MG; Frigerio A
    Cancer Treat Rep; 1976 Apr; 60(4):493-500. PubMed ID: 1277226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue distribution and nucleic acid binding of chlorambucil-3H in tumor-bearing rats.
    Tew KD; Taylor DM
    Experientia; 1978 Sep; 34(9):1215-6. PubMed ID: 720530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the enhancement by cyclophosphamide (NSC-26271) of artificial lung metastasis after labeled cell inoculation.
    de Ruiter J; Smink T; van Putten LM
    Cancer Treat Rep; 1976 Apr; 60(4):465-70. PubMed ID: 1064469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia.
    Hilton J
    Cancer Res; 1984 Nov; 44(11):5156-60. PubMed ID: 6488175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permeation of cyclophosphamide (NSC-26271) metabolites into tumor cells.
    Draeger U; Hohorst HJ
    Cancer Treat Rep; 1976 Apr; 60(4):423-7. PubMed ID: 1277217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem-cell survival and tumor control in the Lewis lung carcinoma.
    Steel GG; Adams K
    Cancer Res; 1975 Jun; 35(6):1530-5. PubMed ID: 1169108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed hematological recovery after cyclophosphamide treatment in the presence of an advanced tumor.
    DeWys WD; Mansky JM
    Cancer Res; 1973 Nov; 33(11):2662-7. PubMed ID: 4748427
    [No Abstract]   [Full Text] [Related]  

  • 11. Different degradation rates of alkylated RNA protein and lipids in normal and tumor cells.
    Lerman MI; Abakumova OY; Kucenco NG; Gorbacheva LB; Kukushkina GV; Serebryanyi AM
    Cancer Res; 1974 Jul; 34(7):1536-41. PubMed ID: 4365228
    [No Abstract]   [Full Text] [Related]  

  • 12. Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy.
    Chen L; Waxman DJ
    Cancer Res; 1995 Feb; 55(3):581-9. PubMed ID: 7834628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enhancement of the toxic effect of endoxan after pretreatment with brain homogenates in rats].
    Ivankovic S; Frank N; Filipovic N; Haupt P; Wiessler M
    Arch Geschwulstforsch; 1982; 52(5):355-61. PubMed ID: 7149909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of antitumor activity of an antibody-interleukin 2 immunocytokine with chemotherapeutic agents.
    Holden SA; Lan Y; Pardo AM; Wesolowski JS; Gillies SD
    Clin Cancer Res; 2001 Sep; 7(9):2862-9. PubMed ID: 11555604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leech salivary gland extract from Haementeria officinalis, a potent inhibitor of cyclophosphamide- and radiation-induced artificial metastasis enhancement.
    Gasic GJ; Iwakawa A; Gasic TB; Viner ED; Milas L
    Cancer Res; 1984 Dec; 44(12 Pt 1):5670-6. PubMed ID: 6498828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
    Naito K; Pellis NR; Kahan BD
    Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of platelet aggregating inhibitor on pulmonary metastases of tumor cells after surgical resection].
    Yano S
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):654-63. PubMed ID: 8225173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
    Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooxidation of cyclophosphamide as an alternative pathway for its bioactivation and lung toxicity.
    Smith RD; Kehrer JP
    Cancer Res; 1991 Jan; 51(2):542-8. PubMed ID: 1985772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts.
    Kennel SJ; Falcioni R; Wesley JW
    Cancer Res; 1991 Mar; 51(5):1529-36. PubMed ID: 1997194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.